Clinical outcome of renin-angiotensin-aldosterone system blockers in treatment of hypertensive patients with COVID-19: a systematic review and meta-analysis

BACKGROUND: Novel coronavirus disease 2019 has been stated as global disease pandemic due to its rapid spread worldwide. Up to 30% of coronavirus disease 2019 patients with hypertension are more susceptible to death. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers have bee...

Descripción completa

Detalles Bibliográficos
Autores principales: Laurentius, Andrea, Mendel, Brian, Prakoso, Radityo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7863036/
https://www.ncbi.nlm.nih.gov/pubmed/33544293
http://dx.doi.org/10.1186/s43044-021-00135-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7863036/
https://www.ncbi.nlm.nih.gov/pubmed/33544293
http://dx.doi.org/10.1186/s43044-021-00135-y

Ejemplares similares